Slingshot members are tracking this event:
In the second half of 2017, Halozyme Therapeutics (HALO) preparing to commence Phase 1 trial on combination of PEG PH20 and atezolizumab in treating gallbladder tumors
Slingshot Insights Explained
Jul 13, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 1, Gallbladder Tumors, Pegph20, Ate Zo Lizumab